User:Julie A. Fogarty

From OpenWetWare
Jump to navigationJump to search

Julie A. Fogarty

"Science does not know its debt to imagination." -Ralph Waldo Emerson

Gerald J. Lieberman Fellow
NSF Graduate Research Fellow
Chemical Engineering
Stanford University
Swartz Lab

Contact Info

Julie Fogarty/Swartz Lab
093 Shriram Center
Chemical Engineering
443 Via Ortega
Stanford, CA 94304

jfogarty {at}


  • 2018 (in progress) - PhD Chemical Engineering, Stanford University
  • 2015 - MS Chemical Engineering, Stanford University
  • 2013 - BS Chemical Engineering, The University of Texas at Austin

Research Interests

  1. Protein Engineering
  2. Vaccine Development & Immunology
  3. Biotechnology Process Development

Julie is working on developing a modular virus-like particle approach for creating novel vaccine candidates for HIV, Influenza, and Zika. The HIV work is a collaboration with Prof. Peter Kim at Stanford University. She is also working on developing the virus-like particles as a modular platform for targeted T-cell antigen delivery in collaboration with Prof. Josh Elias.

Funding Sources

HIV Vaccine - Stanford BioX Program
Influenza Vaccine - Child Health Research Institute, through the Stanford SPARK Program and the Weston Havens Foundation
Zika Vaccine - Stanford SPARK Program
Julie's Personal Funding - NSF Graduate Research Fellowship Program, Gerald J. Lieberman Fellowship

Past Research Experience

Maynard Lab, The University of Texas at Austin, (Sept. 2011 - Aug. 2013)
Peppas Lab, The University of Texas at Austin, (Nov. 2009 - May 2011)
Calin Lab, M.D. Anderson Cancer Center, (June & July 2008)


1. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, and Calin GA. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010 Feb;17(2):246-54. DOI:10.1038/cdd.2009.117|PubMed ID: 19730444|HubMed

2. Fogarty JA and Swartz JR. The exciting potential of modular nanoparticles for rapid development of highly effective vaccines. Curr Opin Chem Eng. 2018 Mar;19:1-8. DOI:10.1016/j.coche.2017.11.001

Press About Julie

04 Mar 2016 Robot bridges the gap between young patients on isolation and hospital school peers, Lucile Packard Children's Hospital Healthier, Happy Lives Blog
20 Mar 2015 Getting her hands dirty, National Science Foundation
19 Dec 2014 Science Friday-style podcast explains work toward a universal flu vaccine, Stanford Medicine Scope Blog
26 Apr 2013 Three Cockrell School Seniors Receive President’s Leadership Awards, University of Texas Cockrell School of Engineering
28 Nov 2012 Undergraduate Julie Fogarty Wins Commended Synthetic Biology Presentation Award, University of Texas McKetta Department of Chemical Engineering